Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paroxetine and IPT in Late-Life Depression (MTLD-2)
NCT00178100Phase 4Completed
- Sponsor
- University of Pittsburgh
- Start
- Mar 1999
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of paroxetine in major depressive disorder (MDD), sponsored by University of Pittsburgh. Started Mar 1999; status: completed.
02
Drugs
paroxetine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00178100.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00178100.